Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA), M4/UTM
0060774
Ordering Recommendation
Viral transport media (eg, M4/UTM) is not preferred when testing for Chlamydia trachomatis and Neisseria gonorrhoeae by transcription-mediated amplification (TMA). Use of transport media other than Aptima specimen collection kit may result in reduced sensitivity. The preferred test is Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA) (0060241) or if confirmation of positive results by an alternate nucleic acid target is required, refer to Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA) with Confirmation (2011164).
Mnemonic
CTNG M4
Methodology
Transcription-Mediated Amplification
Performed
Sun-Sat
Reported
1-2 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Vaginal, endocervical, or male urethral swab in viral transport media (M4) or UTM (ARUP supply #12884). Available online through eSupply using ARUP Connect ™ or contact ARUP Client Services at (800) 522-2787. Refer to "Sample Collection for the Diagnosis of STD" under Specimen Handling at www.aruplab.com for specific specimen collection and transport instructions.  
Specimen Preparation
Transport swab in 3 mL viral transport media (M4 or UTM). (Min: 1 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Specimens in any transport media other than indicated above. Specimens from patients that are less than 16 years of age.  
Remarks
Specimen source required.  
Stability
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 months  
Reference Interval
 
 
Test Number Components Reference Interval
0060243Chlamydia trachomatis by Transcription-​Mediated Amplification (TMA) Negative
0060244Neisseria gonorrhoeae by Transcription-​Mediated Amplification (TMA) Negative
Interpretive Data
Use of transport media other than the APTIMA specimen collection kit may result in reduced sensitivity. Specimens should be collected and transported following the instructions in "Sample Collection for the Diagnosis of STD Using Nucleic Acid Amplification Tests" under Specimen Handling at www.aruplab.com.

This test is intended for medical purposes only and is not valid for the evaluation of suspected sexual abuse or for other forensic purposes. In certain contexts, culture may be required to meet applicable laws and regulations for diagnosis of C. trachomatis and N. gonorrhoeae infections. Per 2014 CDC recommendations, this test does not include confirmation of positive results by an alternative nucleic acid target.

See Compliance Statement B: www.aruplab.com/CS
Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
 
Note
 
CPT Code(s)
87491; 87591
Components
Component Test Code*Component Chart NameLOINC
0060775C. trachomatis by TMA, M4/UTM21613-5
0060776N. gonorrhoeae by TMA, M4/UTM24111-7
0060777Specimen Source31208-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Chlamydia and GC TMA panel
  • CT/GC M4/UTM
  • Gonorrhea UTM
  • Nucleic Acid Amplification Test (NAAT)